Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Article in Oral Oncology (July 2024)
The most recent citing publications are shown below. View all 92 publications that cite this research output on Dimensions.
Article in Oral Oncology (July 2024)
Article in BMC Medical Genomics (May 2024)
Book chapter (May 2024)